Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Glehr, M; Breisach, M; Walzer, S; Lohberger, B; Fürst, F; Friesenbichler, J; Rinner, B; Avian, A; Windhager, R; Leithner, A.
The influence of resveratrol on the synovial expression of matrix metalloproteinases and receptor activator of NF-kappaB ligand in rheumatoid arthritis fibroblast-like synoviocytes.
Z Naturforsch C. 2013; 68(7-8):336-342
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Avian Alexander
Breisach Margherita
Friesenbichler Jörg
Glehr Mathias
Leithner Andreas
Lohberger Birgit
Moazedi-Fürst Florentine
Rinner Beate

Dimensions Citations:

Plum Analytics:
Medication of rheumatoid arthritis (RA) remains challenging and often controversial concerning side effects or long-term complications. We investigated the effect of resveratrol, a phytoalexin discussed for its chondro-protective and anti-inflammatory qualities, on the synovial expression of matrix-degrading enzymes like matrix metalloproteinases (MMPs) and bone-remodelling proteins in RA fibroblast-like synoviocytes (FLS). Interleukin-1beta-stimulated RA-FLS were treated with 100 microM resveratrol for 24 h. To evaluate the effect of resveratrol on the amount of bound/combined MMPs, a Luminex xMAP multiplexing technology was used. The alteration in expression of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegrin (OPG) was measured by quantitative real-time polymerase chain reaction (qRT-PCR). Resveratrol reduced the expression of MMP-1 (p = 0.022), MMP-3 (p = 0.021), and MMP-9 (p = 0.047). qRT-PCR showed a significant reduction in the relative abundance of the transcripts of OPG (p = 0.012) and RANKL (p = 0.018). Our in vitro findings indicate that resveratrol could be a new target for further pharmacological studies in the field of RA. In the future it could play a role as a possible substitute or supplement to currently used drugs against RA to prevent cartilage matrix degradation and pathological bone resorption due to inhibition of MMPs and RANKL.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Arthritis, Rheumatoid - metabolism
Female -
Humans -
Male -
Matrix Metalloproteinases - metabolism
Middle Aged -
RANK Ligand - metabolism
Stilbenes - pharmacology
Synovial Membrane - cytology

Find related publications in this database (Keywords)
Rheumatoid Arthritis
Matrix Metalloproteinases
© Med Uni Graz Impressum